GoodRx Earnings: What To Look For From GDRX [Yahoo! Finance]
GoodRx Holdings, Inc. - Class A (GDRX)
Company Research
Source: Yahoo! Finance
Here's what investors should know. GoodRx met analysts' revenue expectations last quarter, reporting revenues of $195.3 million, up 2.8% year on year. It was a slower quarter for the company, with a significant miss of analysts' EPS estimates. It lost 100,000 customers and ended up with a total of 6.5 million. Is GoodRx a buy or sell going into earnings? Read our full analysis here, it's free This quarter, analysts are expecting GoodRx's revenue to grow 1.6% year on year to $199.8 million, slowing from the 6.8% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.10 per share. GoodRx Total Revenue Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. GoodRx has only missed Wall Street's revenue estimates once over the last two years, exceeding top-line expectations by 0.4% on average. Looking at GoodRx's
Show less
Read more
Impact Snapshot
Event Time:
GDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GDRX alerts
High impacting GoodRx Holdings, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
GDRX
News
- GoodRx (NASDAQ:GDRX) had its "sell (d)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- GoodRx (NASDAQ:GDRX) was given a new $4.00 price target on by analysts at Morgan Stanley.MarketBeat
- GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare ConferenceBusiness Wire
- Former Steelers QB struggles in his first start with new team [USA TODAY]USA TODAY
- Smart ways to spend your remaining FSA money before year-end deadline [CBS News]CBS News
GDRX
Earnings
- 11/4/25 - Beat
GDRX
Sec Filings
- 12/12/25 - Form 8-K
- 12/8/25 - Form 4
- 12/8/25 - Form 3/A
- GDRX's page on the SEC website